|
| 广济药业(000952)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-03-31 | 259.47 | 0.73% | 35065.11 | 320.98 | 34398.76 | 97.21% | 股权激励限售股份 | | 2024-11-21 | 60.92 | 0.17% | 34816.94 | 580.45 | 34398.76 | 97.18% | 股权激励限售股份 | | 2023-04-20 | 3753.91 | 10.61% | 34398.76 | 998.63 | 30644.85 | 86.57% | 定向增发机构配售股份 | | 2021-04-13 | 800.83 | 2.31% | 30945.59 | 3753.91 | 34699.50 | 100.00% | 增发A股法人配售上市 | | 2009-08-04 | 1591.18 | 6.32% | 25170.55 | 0.00 | 25170.55 | 100.00% | 股权分置限售流通 | | 2008-07-30 | 1657.71 | 6.59% | 23575.66 | 1594.89 | 25170.55 | 100.00% | 股权分置限售流通 | | 2007-11-15 | 1328.79 | 5.28% | 21921.66 | 3248.89 | 25170.55 | 100.00% | 股权分置限售流通 | | 2007-07-25 | 6041.15 | 24.00% | 20592.88 | 4577.67 | 25170.55 | 100.00% | 股权分置限售流通 |
|